Renliang Pharmaceutical (Hong Kong) Limited
懏亿设计有限公司
Renliang Pharmaceutical (Hong Kong) Limited (懏億設計有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its official Company Registration Number (CR) is 3260552, and Business Registration Number (BRN) is 75130230, classified as a Private company limited by shares. Incorporated on 2021-11-22, the entity has maintained continuous statutory operations for 4 years, currently holding an active legal status of Live. The registered office is situated at UNIT E35 ON 3RD FLOOR SUPERLUCK, INDUSTRIAL CENTRE (PHASE 2) N0.57 SHA, TSUI ROAD TSUEN WAN NEW TERRITORIES, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 懏億設計有限公司 | Official English Name | Renliang Pharmaceutical (Hong Kong) Limited |
|---|---|---|---|
| Business Reg No. (BRN) | 75130230 | Company Reg No. (CR) | 3260552 |
| Company Category | Private company limited by shares | Incorporation Date | 2021-11-22 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-11-22 |
| Registered Office Address |
UNIT E35 ON 3RD FLOOR SUPERLUCK, INDUSTRIAL CENTRE (PHASE 2) N0.57 SHA, TSUI ROAD TSUEN WAN NEW TERRITORIES, HONG KONG
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-11-22 | NAR1 |
NAR1 Statutory Filing
|
14 | ¥28.00 | ||
| 2 | 2025-11-22 | NAR1 |
NAR1 Statutory Filing
|
19 | ¥28.00 | ||
| 3 | 2025-11-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 | ||
| 4 | 2024-11-22 | NAR1 |
NAR1 Statutory Filing
|
18 | ¥28.00 | ||
| 5 | 2023-11-22 | NAR1 |
NAR1 Statutory Filing
|
17 | ¥28.00 | ||
| 6 | 2022-11-22 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 | ||
| 7 | 2021-11-22 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 8 | 2021-11-22 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
RUITAI INTERNATIONAL TRAD…
瑞泰国际贸易(香港)有限公司
JIAHE Service Limited
加禾咨詢服务有限公司
Hong Kong United Communic…
香港合联讯有限公司
CoolShare Global Technolo…
CopperKey Trading Limited
铜鑰贸易有限公司